Seppalå M, Hirvonen E, Ranta T
Lancet. 1976 May 29;1(7970):1154-6. doi: 10.1016/s0140-6736(76)91542-7.
Bromocriptine 2-5 mg twice daily is effective in the treatment of both normoprolactinaemic and hyperprolactinaemic secondary amenorrhoea. This was demonstrated by the restoration of menstrual cycle and/or ovulation in 9 of 18 normoprolactinaemic and in 8 of 14 hyperprolactinaemic patients taking bromocriptine. Serum-prolactin level decreased in both groups of patients, and usually menstruation was recovered within 8 weeks'treatment. Galactorrhoea disappeared in 7 of 9 hyperprolactinaemic patients, and 2 became pregnant. After treatment had ceased spontaneous menstrual activity continued in 4 patients. 16 patients had side-effects the commonest being nausea and vertigo. These usually disappeared with the dosage was reduced, but 5 patients refused to continue. These results point to a new approach in the treatment of secondary amenorrhoea, even in those patients whose clinical findings give no indication of prolactin suppression.
每日两次服用2 - 5毫克溴隐亭对治疗正常催乳素血症和高催乳素血症引起的继发性闭经均有效。服用溴隐亭的18例正常催乳素血症患者中有9例、14例高催乳素血症患者中有8例月经周期和/或排卵恢复,证实了这一点。两组患者的血清催乳素水平均下降,通常在治疗8周内月经恢复。9例高催乳素血症患者中有7例溢乳消失,2例怀孕。停止治疗后,4例患者月经自行恢复。16例患者出现副作用,最常见的是恶心和眩晕。这些副作用通常在减少剂量后消失,但5例患者拒绝继续治疗。这些结果为继发性闭经的治疗指明了一种新方法,即使是那些临床检查未提示催乳素受抑制的患者。